Exocuf

Exocuf is a combination pharmaceutical product marketed by Ambiens Pharmaceuticals for the management of productive cough and respiratory congestion. It typically contains a combination of terbutaline (a bronchodilator), ambroxol (a mucolytic), guaifenesin (an expectorant), and menthol. Terbutaline acts as a beta-2 adrenergic agonist to relax bronchial smooth muscle, while ambroxol and guaifenesin work to decrease mucus viscosity and facilitate its expulsion from the respiratory tract. Menthol is included for its soothing properties and cooling effect on the throat. It is indicated for conditions such as bronchitis, bronchial asthma, and other obstructive airway diseases where excessive mucus production is a factor.

Brand names

Exocuf

Other names

terbutaline + ambroxol + guaifenesin + menthol